1. UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL. (June 2017) Authors: Davids, M.S.; Kim, H.T.; Nicotra, A.; Savell, A.; Francoeur, K.; Hellman, J.M.; Miskin, H.; Sportelli, P.; Bashey, A.; Stampleman, L.; Rueter, J.; Boruchov, A.; Arnason, J.E.; Jacobson, C.A.; Jacobsen, E.J.; Fisher, D.C.; Brown, J.R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗